{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T18:25:12Z","timestamp":1784053512520,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12920-015-0156-3","type":"journal-article","created":{"date-parts":[[2015,12,3]],"date-time":"2015-12-03T03:09:04Z","timestamp":1449112144000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["IL-10R\u03b1 expression is post-transcriptionally regulated by miR-15a, miR-185, and miR-211 in melanoma"],"prefix":"10.1186","volume":"8","author":[{"given":"Isabella","family":"Venza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Visalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"Beninati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Benfatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Teti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Venza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,3]]},"reference":[{"key":"156_CR1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.11613\/BM.2015.004","volume":"25","author":"J Trifunovi\u0107","year":"2015","unstructured":"Trifunovi\u0107 J, Miller L, Debeljak \u017d, Horvat V. Pathologic patterns of interleukin 10 expression--a review. Biochem Med (Zagreb). 2015;25:36\u201348.","journal-title":"Biochem Med (Zagreb)"},{"key":"156_CR2","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1158\/0008-5472.CAN-05-4128","volume":"66","author":"R Kim","year":"2006","unstructured":"Kim R, Emi M, Tanabe K, Arihiro K. Tumor-driven evolution of immunosuppressive networks during malignant progression. Cancer Res. 2006;66:5527\u201336.","journal-title":"Cancer Res"},{"key":"156_CR3","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1189\/jlb.0705358","volume":"78","author":"S Mocellin","year":"2005","unstructured":"Mocellin S, Marincola FM, Young HA. Interleukin-10 and the immune response against cancer: a counterpoint. J Leukoc Biol. 2005;78:1043\u201351.","journal-title":"J Leukoc Biol"},{"key":"156_CR4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1124\/pr.55.2.4","volume":"55","author":"K Asadullah","year":"2003","unstructured":"Asadullah K, Sterry W, Volk HD. Interleukin-10 therapy--review of a new approach. Pharmacol Rev. 2003;55:241\u201369.","journal-title":"Pharmacol Rev"},{"key":"156_CR5","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/bjc.1994.469","volume":"70","author":"S Kr\u00fcger-Krasagakes","year":"1994","unstructured":"Kr\u00fcger-Krasagakes S, Krasagakis K, Garbe C, Schmitt E, H\u00fcls C, Blankenstein T, et al. Expression of interleukin 10 in human melanoma. Br J Cancer. 1994;70:1182\u20135.","journal-title":"Br J Cancer"},{"key":"156_CR6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/hum.1996.7.1-23","volume":"7","author":"CM G\u00e9rard","year":"1996","unstructured":"G\u00e9rard CM, Bruyns C, Delvaux A, Baudson N, Dargent JL, Goldman M, et al. Loss of tumorigenicity and increased immunogenicity induced by interleukin-10 gene transfer in B16 melanoma cells. Hum Gene Ther. 1996;7:23\u201331.","journal-title":"Hum Gene Ther"},{"key":"156_CR7","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/(SICI)1097-0215(19970516)71:4<630::AID-IJC20>3.0.CO;2-E","volume":"71","author":"FY Yue","year":"1997","unstructured":"Yue FY, Dummer R, Geertsen R, Hofbauer G, Laine E, Manolio S, et al. Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules. Int J Cancer. 1997;71:630\u20137.","journal-title":"Int J Cancer"},{"key":"156_CR8","first-page":"1969","volume":"2","author":"S Huang","year":"1996","unstructured":"Huang S, Xie K, Bucana CD, Ullrich SE, Bar-Eli M. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis. Clin Cancer Res. 1996;2:1969\u201379.","journal-title":"Clin Cancer Res"},{"key":"156_CR9","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/ijc.2910560524","volume":"56","author":"Q Chen","year":"1994","unstructured":"Chen Q, Daniel V, Maher DW, Hersey P. Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanoma. Int J Cancer. 1994;56:755\u201360.","journal-title":"Int J Cancer"},{"key":"156_CR10","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1182\/blood.V98.7.2143","volume":"98","author":"S Fujii","year":"2001","unstructured":"Fujii S, Shimizu K, Shimizu T, Lotze MT. Interleukin-10 promotes the maintenance of antitumor CD8(+) T-cell effector function in situ. Blood. 2001;98:2143\u201351.","journal-title":"Blood"},{"key":"156_CR11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.abb.2014.07.022","volume":"563","author":"MN Aftab","year":"2014","unstructured":"Aftab MN, Dinger ME, Perera RJ. The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma. Arch Biochem Biophys. 2014;563:60\u201370.","journal-title":"Arch Biochem Biophys"},{"key":"156_CR12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2172-11-27","volume":"11","author":"A Bolpetti","year":"2010","unstructured":"Bolpetti A, Silva JS, Villa LL, Lepique AP. Interleukin-10 production by tumor infiltrating macrophages plays a role in Human Papillomavirus 16 tumor growth. BMC Immunol. 2010;11:27.","journal-title":"BMC Immunol"},{"key":"156_CR13","doi-asserted-by":"crossref","first-page":"54358","DOI":"10.1074\/jbc.M405331200","volume":"279","author":"A Srisodsai","year":"2004","unstructured":"Srisodsai A, Kurotani R, Chiba Y, Sheikh F, Young HA, Donnelly RP, et al. Interleukin-10 induces uteroglobin-related protein (UGRP) 1 gene expression in lung epithelial cells through homeodomain transcription factor T\/EBP\/NKX2.1. J Biol Chem. 2004;279:54358\u201368.","journal-title":"J Biol Chem"},{"key":"156_CR14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/exd.12629","volume":"24","author":"AP Wiguna","year":"2015","unstructured":"Wiguna AP, Walden P. Role of IL-10 and TGF-\u03b2 in melanoma. Exp Dermatol. 2015;24:209\u201314.","journal-title":"Exp Dermatol"},{"key":"156_CR15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1046\/j.1365-2567.1999.00828.x","volume":"98","author":"AW Rowbottom","year":"1999","unstructured":"Rowbottom AW, Lepper MA, Garland RJ, Cox CV, Corley EG. Interleukin-10-induced CD8 cell proliferation. Immunology. 1999;98:80\u20139.","journal-title":"Immunology"},{"key":"156_CR16","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1006\/cyto.1999.0614","volume":"12","author":"E L\u00e1z\u00e1r-Moln\u00e1r","year":"2000","unstructured":"L\u00e1z\u00e1r-Moln\u00e1r E, Hegyesi H, T\u00f3th S, Falus A. Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine. 2000;12:547\u201354.","journal-title":"Cytokine"},{"key":"156_CR17","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/CMR.0b013e32833c1b5d","volume":"20","author":"J Reiche","year":"2010","unstructured":"Reiche J, Pauli G, Ellerbrok H. Differential expression of human endogenous retrovirus K transcripts in primary human melanocytes and melanoma cell lines after UV irradiation. Melanoma Res. 2010;20:435\u201340.","journal-title":"Melanoma Res"},{"key":"156_CR18","doi-asserted-by":"crossref","first-page":"e36762","DOI":"10.1371\/journal.pone.0036762","volume":"7","author":"M Chartrain","year":"2012","unstructured":"Chartrain M, Riond J, Stennevin A, Van den Berghe I, Gomes B, Lamant L, et al. Melanoma chemotherapy leads to the selection of ABCB5-expressing cells. PLoS One. 2012;7:e36762.","journal-title":"PLoS One"},{"key":"156_CR19","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.bbrc.2013.10.114","volume":"441","author":"M Venza","year":"2013","unstructured":"Venza M, Visalli M, Catalano T, Fortunato C, Oteri R, Teti D, et al. Impact of DNA methyltransferases on the epigenetic regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in malignant melanoma. Biochem Biophys Res Commun. 2013;441:743\u201350.","journal-title":"Biochem Biophys Res Commun"},{"key":"156_CR20","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1006\/excr.1993.1102","volume":"205","author":"IC LePoole","year":"1993","unstructured":"LePoole IC, Van Den Wungaard RM, Westerhof W, Verkruisen RP, Dutrieux RP, Dingermans KP, et al. Phagocytosis by normal human melanocytes in vitro. Exp Cell Res. 1993;205:388\u201395.","journal-title":"Exp Cell Res"},{"key":"156_CR21","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/jid.1965.160","volume":"45","author":"CM Papa","year":"1965","unstructured":"Papa CM, Kligman AM. The behavior of melanocytes in inflammation. J Invest Dermatol. 1965;45:465\u201374.","journal-title":"J Invest Dermatol"},{"key":"156_CR22","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1177\/1430.15828","volume":"100","author":"M Venza","year":"2014","unstructured":"Venza M, Dell\u2019Aversana C, Visalli M, Altucci L, Teti D, Venza I. Identification of microRNA expression patterns in cutaneous and uveal melanoma cell lines. Tumori. 2014;100:e4\u20137.","journal-title":"Tumori"},{"key":"156_CR23","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/cdd.2014.87","volume":"22","author":"Y Pekarsky","year":"2015","unstructured":"Pekarsky Y, Croce CM. Role of miR-15\/16 in CLL. Cell Death Differ. 2015;22:6\u201311.","journal-title":"Cell Death Differ"},{"key":"156_CR24","doi-asserted-by":"crossref","first-page":"e18936","DOI":"10.1371\/journal.pone.0018936","volume":"6","author":"E Greenberg","year":"2011","unstructured":"Greenberg E, Hershkovitz L, Itzhaki O, Hajdu S, Nemlich Y, Ortenberg R, et al. Regulation of cancer aggressive features in melanoma cells by microRNAs. PLoS One. 2011;6:e18936.","journal-title":"PLoS One"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-015-0156-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T03:31:41Z","timestamp":1653708701000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1755-8794\/8\/81"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["156"],"URL":"https:\/\/doi.org\/10.1186\/s12920-015-0156-3","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"81"}}